The Democratic Republic of Congo (DRC) is grappling with a severe mpox (previously known as monkeypox) outbreak as the number of cases and deaths continues to rise. The health minister of DRC reported on Monday that the death toll has now surpassed 570, up from 548 just days earlier. The total number of cases has also increased from 16,000 to 16,700.
DRC Health Minister Samuel-Roger Kamba described the situation as a “continental emergency” during a press briefing. The World Health Organisation (WHO) has classified the surge in Africa as a global public health emergency, urging affected nations to accelerate vaccination efforts to combat a more virulent strain of the virus.
The outbreak has spread to several countries in Africa, including Burundi, Kenya, Rwanda, and Uganda, with a new strain also identified in Sweden. The situation in DRC is particularly dire, with cases reported across all 26 provinces of the nation, which has a population of approximately 100 million.
In response to the crisis, the United States has pledged 50,000 doses of the vaccine, while Japan has committed to sending 3.5 million doses specifically for children. The DRC plans to vaccinate four million people, including 3.5 million children, with the incoming supplies. Health Minister Kamba expressed hope that the vaccines will arrive within the next week, emphasizing that vaccination is crucial for controlling the outbreak.
The WHO has updated its guidelines to address the surge, calling for enhanced immunization strategies and detailed investigation of cases to understand transmission and prevent further spread. It has emphasized the need for countries to support mpox patients with food, isolation in care centers, and home-based care where necessary. The organization also stresses the importance of cross-border collaboration to manage the outbreak effectively without imposing undue restrictions on travel and trade.
Mpox, previously known as monkeypox, is caused by a virus transmitted from infected animals to humans, and can also spread through close human contact. The disease is characterized by fever, muscle aches, and large boil-like skin lesions. A new strain, clade 1b, has been identified as more deadly, with a mortality rate of about 3.6%, particularly affecting children.
As the DRC awaits the arrival of vaccines, the situation remains critical, with the hope that increased vaccination efforts will help curb the spread of this serious disease.
